MENU × BUSINESS
Banking And InsuranceCryptocurrencyDigital MarketingErpFood And BeveragesHealthcareLegalMarketing And AdvertisingMedia And EntertainmentMetals And MiningOil And GasRetailTelecom
TECHNOLOGY
Artificial IntelligenceBig DataCloudCyber SecurityE CommerceEducationGaming And VfxIT ServiceMobileNetworkingSAPScience And TechnologySecuritySoftwareStorage
PLATFORM
CiscoDatabaseGoogleIBMJuniperM2MMicrosoftOracleOracleRed Hat
LEADERSHIP
CEO ReviewCompany Review
MAGAZINE
ASIA INDIA
STARTUPS CLIENT SPEAK CONTACT US

The Silicon Review Asia

Innaccel’s Neo-Natal Respiratory System Seeks to Reduce the Gaps in the Current CPAP Treatments

Innaccel’s Neo-Natal Respiratory System Seeks to Reduce the Gaps in the Current CPAP Treatments

InnAccel aims to deliver respiratory support to newborns that would relieve them of their respiratory problems occurring at the time of shifting them to super-speciality hospitals from primary health care centres. In order to do that, the Bengaluru based startup has come up with its portable neo-natal CPAP (Continuous Positive Airwave Pressure) systemcalled as SAANS that is infrastructure independent as well.

SAANS has been developed by InnAccel’s own division, Coeo Labs, and is the only CPAP device that supports multiple power options as well as a patented manual mode. The device doesn’t require any high level of expertise to operate and can be highly effective to reduce one of the country’s major causes of infantmortality. The company has said that the product has been conceptualized in collaboration with Dr. Kristian Olson (USA) and Dr. Data Santorino (Uganda) of the Consortium of Affordable Medical Technologies (CAMTech).

SAANS is developed keeping the transport and secondary care settings in view so that the CPAP device can yield unblended air as output, i.e. an air-oxygen mixture or oxygen as needed. This enables physicians to regulate the flow and pressure of air according to the suggested ranges for neonatal CPAP. Currently, the product is going through clinical evaluation. It has been tested on a few neonates and the results have been promising with a survival rate of 100%.

With SAANS, InnAccel hopes to target rural areas where babies fail to receive CPAP treatment due to limited facilities. Moreover, the current CPAP devices are expensive and can only be used in the Neo-natal Intensive Care Unit (NICU). InnAccel wants to eliminate this gap in the market.

YOU MAY ALSO LIKE

Marketing Partnership: NBA, McDonald’s Will Jointly open NBA Experience Zones India

There is good news for all basketball fans in India. Very soon, NBA themed promotions and experience zones will be launched in India. The announcement...

Dunzo to Raise Funds from Google, others

Dunzo, the app which is trying to make life easier for the people upto some extent plans to raise about Rs. 183 crore from different investors which a...

Sapta Shakti Command Will Be Displaying Defence Technology Equipment at Jaipur Military Station

This event is organised with an aim to provide an opportunity where one and all can experience the developments in the field of defence and security-r...

Samsung is All Set to Roll out Its Galaxy A9 Smartphone On November 20

After Samsung unveiled its new Galaxy A9 smartphone in Singapore last month, the company is all set to launch it in India on November 20. In Singapore...

RECOMMENDED